About this trial
The aim of the study is to compare outcomes between patients receiving standard C-section wound closure compared to a wound closure bundle that includes Stratafix sutures and Dermabond PRINEO.
Eligibility criteria
Qualifiers
Patient must be 18 years of age or older at time of recruitment
Patients opting for a planned (elective) C-Section (13-36 weeks gestation) will be eligible to consent.
Patients must have internet access and/or a smartphone in order to access the digital platform to complete the study questionnaires
Patients must speak and write in English as study questionnaires will only be provided in English
Disqualifiers
Ability to consent or use the virtual care platform (e.g., patients with intellectual disabilities)
Expectation of significant maternal complications that may affect the surgery
Patients who enroll in the study but have an unplanned emergency C-section
Trial design
Treatments tested in this trial
- Stratafix Suture
- DERMABOND PRINEO
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and collaborators
North York General Hospital
Lead sponsor
Johnson & Johnson
Collaborator